Abstract
In this issue of Blood, Fish et al uncover how Epstein-Barr virus (EBV) enhances MYC-driven B-cell lymphoma by crossing EBV Em-EBV latent membrane protein 2A (LMP2A) transgenic mice with immunoglobulin-l (Igl)-MYC transgenic mice.
MeSH terms
-
Animals
-
Gene Expression Regulation, Neoplastic*
-
Humans
-
Lymphoma, B-Cell / metabolism*
-
Proto-Oncogene Proteins c-myc / metabolism*
-
Viral Matrix Proteins / metabolism*
Substances
-
EBV-associated membrane antigen, Epstein-Barr virus
-
Proto-Oncogene Proteins c-myc
-
Viral Matrix Proteins